Ben Withey
Director, Commercial Diagnostics, CDx Lead Pfizer
Seminars
Thursday 25th September 2025
Good not Great: Appropriate Use of LDTs to Drive Access to Precision Medicine
12:20 pm
- Review the importance of the relationship between your CDx and its LDTs
- Exploring what good looks like, via a review of the bad
- Showcasing how early planning can help
Tuesday 23rd September 2025
Panel Discussion: Navigating the Common Pitfalls in Digital Pathology to Streamline CDx Development & Adoption
9:50 am
- What are the key strategies to overcome barriers to widespread adoption of digital pathology? And how can organizations build the necessary infrastructure to support digital pathology at scale?
- What are the commercial challenges facing digital pathology as a companion diagnostic and how can companies address these obstacles?
- What are the current regulatory challenges in getting digital pathology technologies approved for use as CDx, and how can these be addressed moving forward?
